CCR7 Is Critical for the Induction and Maintenance of Th17 Immunity in Dry Eye Disease
Author(s) -
Shilpa Kodati,
Sunil K. Chauhan,
Yihe Chen,
Thomas H. Dohlman,
Parisa Karimian,
Daniel R. Saban,
Reza Dana
Publication year - 2014
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.14-14481
Subject(s) - c c chemokine receptor type 7 , immunology , medicine , chemokine , blockade , chemokine receptor , isotype , immunity , t cell , immune system , antibody , receptor , monoclonal antibody
We characterized antigen-presenting cell (APC)-relevant chemokine receptor expression in dry eye disease (DED), and investigated the effect of topical CC chemokine receptor (CCR)-7 blockade specifically on Th17 cell immunity and dry eye disease severity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom